Dernière nouvelles - Ypsomed

Annual General Meeting of Ypsomed elects new Chairman

30/06/2022 - 07:00 Press Releases Ypsomed Group

Burgdorf – Ypsomed's Annual General Meeting on 29 June 2022 approved all the proposals of the Board of Directors. It elected Gilbert Achermann as the new Chairman of the Board of Directors and Simon Michel as a new member of the Board of Directors. The founder and long-standing Chairman Dr. h.c. Willy Michel was given a ceremonial farewell.

Sujets:

Management

En savoir plus... Annual General Meeting of Ypsomed elects new Chairman

Ypsomed, Abbott and CamDiab unveil new automated insulin delivery partnership for people with diabetes

27/04/2022 - 06:00 Press Releases Ypsomed Group

Burgdorf – Ypsomed, Abbott and CamDiab will work to accelerate the development of an automated insulin delivery system for people living with diabetes. The system is being designed to include Abbott’s FreeStyle Libre 3 sensor, CamDiab’s CamAPS FX algorithm, and Ypsomed’s mylife YpsoPump. The partnership demonstrates the companies’ collective desire to drive integrated solutions to help people with diabetes better manage their condition and improve health outcomes.

Sujets:

Innovation & Digital Health

En savoir plus... Ypsomed, Abbott and CamDiab unveil new automated insulin delivery partnership for people with diabetes

Ypsomed, Abbott et CamDiab dévoilent un nouveau partenariat d'administration automatisée d'insuline pour les personnes vivant avec le diabète

27/04/2022 - 06:00 Communiqués Ypsomed Canada

Berthoud - Ypsomed, Abbott et CamDiab travailleront pour accélérer le développement d'un système d'administration automatisée d'insuline pour les personnes vivant avec le diabète. Le système est conçu pour inclure le capteur FreeStyle Libre 3 d'Abbott, l'algorithme CamAPS FX de CamDiab et la pompe mylife YpsoPump d'Ypsomed. Le partenariat démontre la volonté collective des entreprises de proposer des solutions intégrées pour aider les personnes vivant avec le diabète à mieux gérer leur condition et à améliorer leur état de santé.

En savoir plus... Ypsomed, Abbott et CamDiab dévoilent un nouveau partenariat d'administration automatisée d'insuline pour les personnes vivant avec le diabète

Ypsomed partners with CamDiab Ltd to drive on smartphone based adaptive automated insulin delivery (AID)

22/03/2022 - 07:00 Press Releases Ypsomed Group

Burgdorf – Ypsomed partners with CamDiab Ltd, the developer of CamAPS FX, an app to manage glucose levels via insulin pumps using an adaptive, hybrid closed-loop approach. During the first half of 2022, this easy-to-use loop solution will be launched for the mylife YpsoPump system, starting in selected major countries in Europe and followed by other territories in the course of the year. Patients can then connect the mylife YpsoPump system to the mylife CamAPS FX Android mobile application and are enabled to algorithm-based insulin delivery support including bolus from the personal smartphone.

Sujets:

Innovation & Digital Health

En savoir plus... Ypsomed partners with CamDiab Ltd to drive on smartphone based adaptive automated insulin delivery (AID)

Sébastien Delarive to become new Senior Vice President Diabetes Care.

Ypsomed focuses on growth and strengthens its business units

23/02/2022 - 07:00 Press Releases Ypsomed Group

Burgdorf – With the aim of focusing on changing customer needs, Ypsomed is stepwise optimizing the organisation of the business units and the Management Board.

Sujets:

Access & Expansion

En savoir plus... Ypsomed focuses on growth and strengthens its business units